134 related articles for article (PubMed ID: 24569408)
1. [Pharmacological, metabolic and clinical aspects of new oral contraceptive associations containing natural estrogens].
Ferrari S; Piacenti I; Napolitano A; Cagnacci A
Minerva Ginecol; 2014 Feb; 66(1):91-102. PubMed ID: 24569408
[TBL] [Abstract][Full Text] [Related]
2. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
[TBL] [Abstract][Full Text] [Related]
3. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
4. Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol.
Sørdal T; Grob P; Verhoeven C
Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1279-85. PubMed ID: 22762147
[TBL] [Abstract][Full Text] [Related]
5. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
6. The use of newer progestins for contraception.
Sitruk-Ware R; Nath A
Contraception; 2010 Nov; 82(5):410-7. PubMed ID: 20933114
[TBL] [Abstract][Full Text] [Related]
7. Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
Haverinen AH; Luiro KM; Szanto T; Kangasniemi MH; Hiltunen L; Sainio S; Piltonen TT; Lassila R; Tapanainen JS; Heikinheimo O
Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1102-1111. PubMed ID: 35909329
[TBL] [Abstract][Full Text] [Related]
8. Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
Kangasniemi MH; Arffman RK; Joenväärä S; Haverinen A; Luiro K; Tohmola T; Renkonen R; Heikinheimo O; Tapanainen JS; Piltonen TT
Hum Reprod; 2023 Jan; 38(1):89-102. PubMed ID: 36416543
[TBL] [Abstract][Full Text] [Related]
9. Metabolic impact of combined hormonal contraceptives containing estradiol.
Grandi G; Napolitano A; Cagnacci A
Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):779-87. PubMed ID: 27187588
[TBL] [Abstract][Full Text] [Related]
10. Effect of dienogest-containing oral contraceptives on lipid metabolism.
Wiegratz I; Lee JH; Kutschera E; Bauer HH; von Hayn C; Moore C; Mellinger U; Winkler UH; Gross W; Kuhl H
Contraception; 2002 Mar; 65(3):223-9. PubMed ID: 11929644
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of contraceptive steroids.
Sitruk-Ware R; Nath A
Rev Endocr Metab Disord; 2011 Jun; 12(2):63-75. PubMed ID: 21538049
[TBL] [Abstract][Full Text] [Related]
12. New progestagens for contraceptive use.
Sitruk-Ware R
Hum Reprod Update; 2006; 12(2):169-78. PubMed ID: 16291771
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
14. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
Gaussem P; Alhenc-Gelas M; Thomas JL; Bachelot-Loza C; Remones V; Ali FD; Aiach M; Scarabin PY
Thromb Haemost; 2011 Mar; 105(3):560-7. PubMed ID: 21225090
[TBL] [Abstract][Full Text] [Related]
15. Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability.
Akintomide H; Panicker S
Open Access J Contracept; 2015; 6():77-86. PubMed ID: 29386925
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
Grandi G; Napolitano A; Xholli A; Tirelli A; Di Carlo C; Cagnacci A
Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
[TBL] [Abstract][Full Text] [Related]
17. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol.
Duijkers IJ; Klipping C; Grob P; Korver T
Eur J Contracept Reprod Health Care; 2010 Oct; 15(5):314-25. PubMed ID: 20695770
[TBL] [Abstract][Full Text] [Related]
18. Effect of four oral contraceptives on hemostatic parameters.
Wiegratz I; Lee JH; Kutschera E; Winkler UH; Kuhl H
Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
[TBL] [Abstract][Full Text] [Related]
19. Nomegestrol acetate, a novel progestogen for oral contraception.
Mueck AO; Sitruk-Ware R
Steroids; 2011 May; 76(6):531-9. PubMed ID: 21335021
[TBL] [Abstract][Full Text] [Related]
20. The pharmacology of nomegestrol acetate.
Ruan X; Seeger H; Mueck AO
Maturitas; 2012 Apr; 71(4):345-53. PubMed ID: 22364709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
